Zymeworks (ZYME) Other Non Operating Income (2021 - 2022)
Zymeworks' (ZYME) quarterly Other Non Operating Income came in at $1.4 million in Q3 2022, up 67.86% year-on-year from $809000.0 in Q3 2021, and up 67.86% quarter-over-quarter from $809000.0 in Q3 2021.
Zymeworks (ZYME) Other Non Operating Income (2021 - 2022) Analysis & Trends
Zymeworks has disclosed Other Non Operating Income across 2 years of filings, most recently posting $1.4 million for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.36 Mn |
| Sep 30, 2021 | 809,000.00 |